13F HOLDINGS REPORT
Aquilo Capital Management, LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001591986-25-000003
Total Value
$66.3M
Positions
15
Other Managers
0
Confidential Omitted
No
Holdings (15)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 707,589 | $13.3M | 20.06% |
| 2 | BLUEPRINT MEDICINES CORP | 09627Y109 | 129,600 | $11.3M | 17.04% |
| 3 | KYMERA THERAPEUTICS INC | KYMR | 183,521 | $7.4M | 11.13% |
| 4 | AMGEN INC | AMGN | 25,000 | $6.5M | 9.83% |
| 5 | ARVINAS INC | ARVN | 328,766 | $6.3M | 9.50% |
| 6 | BICYCLE THERAPEUTICS PLC | BCYC | 221,911 | $3.1M | 4.68% |
| 7 | PROTAGONIST THERAPEUTICS INC | PTGX | 76,592 | $3.0M | 4.46% |
| 8 | REGENXBIO INC | RGNX | 346,302 | $2.7M | 4.04% |
| 9 | IMMATICS N.V | IMTX | 373,902 | $2.7M | 4.01% |
| 10 | SILENCE THERAPEUTICS PLC | SLNCF | 367,214 | $2.5M | 3.81% |
| 11 | ADICET BIO INC | ACET | 2,531,194 | $2.4M | 3.67% |
| 12 | PRECISION BIOSCIENCES INC | DTIL | 536,376 | $2.0M | 3.08% |
| 13 | REPARE THERAPEUTICS INC | 760273102 | 1,293,715 | $1.7M | 2.56% |
| 14 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 75,000 | $1.4M | 2.13% |
| 15 | SUTRO BIOPHARMA INC | STRO | 498 | $916 | 0.00% |